Clinical trials
Active, not recruiting Breast Neoplasms trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 5 |
| Eli Lilly and Company | 4 |
| Chinese University of Hong Kong | 2 |
| The University of Hong Kong | 2 |
| AstraZeneca | 1 |
| DualityBio Inc. | 1 |
| Gilead Sciences | 1 |
| NRG Oncology | 1 |
| Novartis Pharmaceuticals | 1 |
| Olema Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 20 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Melanoma | 3 |
| Brain Neoplasms | 2 |
| Carcinoma, Intraductal, Noninfiltrating | 2 |
| Carcinoma, Renal Cell | 2 |
| Central Nervous System Neoplasms | 2 |
| Cholangiocarcinoma | 2 |
| Colonic Neoplasms | 2 |
| Colorectal Neoplasms | 2 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.